• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number SE-06-100-080-6F
Device Problem Break (1069)
Patient Problems Thrombosis (2100); Claudication (2550)
Event Date 09/01/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The udi is unknown because the part and lot numbers were not provided.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed and a similar incident query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.The investigation was unable to determine the cause for the reported stent fracture and subsequent patient effects.The reported patient effects of thrombosis and claudication are listed as potential patient effects associated with the use of the device and are listed in the supera instruction for use.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported at the leipzig interventional course (linc) 2019 conference in (b)(6) an event that took place in (b)(6) with an unspecified supera peripheral stent system.The presentation was titled: "endovascular treatment of popliteal thrombosis secondary to supera stent fracture" the procedure occurred around (b)(6) 2018, where right popliteal thrombosis was noted and balloon angioplasty was then performed.An unspecified 6.5mm supera was then implanted.Six months later, severe right limb claudication and in-stent thrombosis was noted.The stent implant became fractured.Endovascular treatment was performed by using intra-stent angioplasty with a second 5.5mm supera stent to cover the fracture of the previous stent.The patient was discharged the next day with medication.Three month follow-up showed the patient remained asymptomatic with preserved distal pulses.The treatment was deemed a feasible and safe technique producing good results.The patient is in good condition.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).Attachment article titled: endovascular treatment of popliteal artery occlusion caused by ruptured supera interwoven nitinol stent.Correction: patient age updated from 60 to 51 years.
 
Event Description
Subsequent to the initially filed mdr report, the article titled: "endovascular treatment of popliteal artery occlusion caused by ruptured supera interwoven nitinol stent" was received.Please see attached article for additional details.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8337625
MDR Text Key136109720
Report Number2024168-2019-01093
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSE-06-100-080-6F
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/23/2019
Initial Date FDA Received02/13/2019
Supplement Dates Manufacturer Received05/21/2019
Supplement Dates FDA Received06/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age51 YR
Patient Weight72
-
-